3
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Effects of Indomethacin on Central, Renal and Coronary Hemodynamics

An Experimental Study in Swine with Unilateral Ureteral Obstruction

, &
Pages 73-79 | Received 22 Sep 1981, Published online: 15 Feb 2010
 

Abstract

The circulatory effects of intravenously administered indomethacin, a potent prostaglandin synthesis inhibitor (0.8 mg/kg bw) were investigated in pigs with unilateral ureteral obstruction. The drug induced a marked but transient increase in systemic arterial pressure (+53%, p<0.02) and pulmonary arterial (+81%, p<0.02) pressure without any changes in left or right sided filling pressures, cardiac output or heart rate. Coronary blood flow remained unchanged and renal venous blood flow decreased (−26%, p<0.02). Renal pelvic pressure decreased (−20%, p<0.02). Thus systemic (SVR), pulmonary (PVR) and coronary vascular resistance (CVR) and renal vascular resistance (RVR) on the obstructed side increased (SVR+73%, p<0.02; PVR+140%, p<0.02; CVR+53%, p<0.02 and RVR+107%, p<0.02 respectively).

Even if one takes into consideration other factors than ureteral obstruction contributing to these reactions, e.g. low volume load, anaesthesia, surgical trauma and species differences, care is adviced in treating patients with coronary artery disease or obstructive lung disease with indomethacin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.